These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1279848)
41. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Suzuki S; Toledo-Pereyra LH; Rodriguez FJ; Cejalvo D Transplantation; 1993 Jun; 55(6):1265-72. PubMed ID: 7685932 [TBL] [Abstract][Full Text] [Related]
43. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells. Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012 [TBL] [Abstract][Full Text] [Related]
44. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor. Tack I; Marin-Castano E; Bascands JL; Pecher C; Ader JL; Girolami JP Br J Pharmacol; 1997 Jun; 121(3):433-40. PubMed ID: 9179384 [TBL] [Abstract][Full Text] [Related]
45. Effects of nicotine on production of endothelin and eicosanoid by bovine pulmonary artery endothelial cells. Suzuki N; Ishii Y; Kitamura S Prostaglandins Leukot Essent Fatty Acids; 1994 Apr; 50(4):193-7. PubMed ID: 8022854 [TBL] [Abstract][Full Text] [Related]
46. Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. Lyson T; Ermel LD; Belshaw PJ; Alberg DG; Schreiber SL; Victor RG Circ Res; 1993 Sep; 73(3):596-602. PubMed ID: 7688670 [TBL] [Abstract][Full Text] [Related]
47. Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin. Massoudy P; Zahler S; Kupatt C; Reder E; Becker BF; Gerlach E J Mol Cell Cardiol; 1997 Feb; 29(2):535-44. PubMed ID: 9140813 [TBL] [Abstract][Full Text] [Related]
48. Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. Yamamoto M; Baba H; Kusumoto T; Sakaguchi Y; Maehara Y; Kuwano M; Sugimachi K Anticancer Drugs; 1995 Aug; 6(4):570-7. PubMed ID: 7579561 [TBL] [Abstract][Full Text] [Related]
49. Application of low dose of FK506 in pancreas transplantation model in Wistar-SD rats. Li F; Wang SX; Li QY; Yin HS Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):673-8. PubMed ID: 22283636 [TBL] [Abstract][Full Text] [Related]
50. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519 [TBL] [Abstract][Full Text] [Related]
51. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Igarashi K; Hirotani H; Woo JT; Stern PH Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740 [TBL] [Abstract][Full Text] [Related]
52. Differential effects of FK506 and cyclosporin A on catecholamine release from bovine adrenal chromaffin cells. Matsumura C; Kuwashima H; Kimura T Auton Autacoid Pharmacol; 2004 Jul; 24(3):55-61. PubMed ID: 15541012 [TBL] [Abstract][Full Text] [Related]
53. Effects of FK506 in rat and human resistance arteries. De Lima JJ; Xue H; Coburn L; Andoh TF; McCarron DA; Bennett WM; Roullet JB Kidney Int; 1999 Apr; 55(4):1518-27. PubMed ID: 10201018 [TBL] [Abstract][Full Text] [Related]
54. Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C. Oriji GK; Keiser HR Am J Hypertens; 1999 Nov; 12(11 Pt 1):1091-7. PubMed ID: 10604485 [TBL] [Abstract][Full Text] [Related]
55. Effect of long-term cyclosporine administration on muscle flap hemodynamics. Unsal M; Gurunluoglu R; Babuccu O; Carnevale K; Siemionow M Ann Plast Surg; 2002 Mar; 48(3):305-11. PubMed ID: 11862037 [TBL] [Abstract][Full Text] [Related]
56. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176 [TBL] [Abstract][Full Text] [Related]
57. Direct and endothelial cell-mediated effect of cyclosporin A on the proliferation of rat smooth muscle cells in vitro. Leszczynski D; Zhao Y; Yeagley TJ; Foegh ML Am J Pathol; 1993 Jan; 142(1):149-55. PubMed ID: 8424452 [TBL] [Abstract][Full Text] [Related]
58. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. Yoshimoto T; Uchino H; He QP; Li PA; Siesjö BK Brain Res; 2001 Apr; 899(1-2):148-58. PubMed ID: 11311876 [TBL] [Abstract][Full Text] [Related]
59. Influence of the rate of infusion on cyclosporine nephrotoxicity in the rat. Finn WF; McCormack AJ; Sullivan BA; Hak LJ; Clark RL Ren Fail; 1989; 11(1):3-15. PubMed ID: 2772285 [TBL] [Abstract][Full Text] [Related]
60. The immunosuppressive drug mycophenolic acid reduces endothelin-1 synthesis in endothelial cells and renal epithelial cells. Haug C; Schmid-Kotsas A; Linder T; Jehle PM; Bachem MG; Gruenert A; Rozdzinski E Clin Sci (Lond); 2002 Aug; 103 Suppl 48():76S-80S. PubMed ID: 12193059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]